Prevalence of BCG scar among BCG-vaccinated children in a southern Nigeria tertiary hospital
Abstract
Abstract:
Background: The burden of tuberculosis is high in Nigeria as in other developing countries. The administration of BCG
vaccine to neonates is essential in the control of tuberculosis. A scar usually develops 6 – 8 weeks later at the site of vaccination, which can be used clinically as a proof of vaccination. Not all vaccinated infants however, develop a BCG scar.
Objectives: To determine the prevalence of scar formation postvaccination and to unravel, if present, any factors responsible for
scar failure. Methods: Two hundred and fourteen children were consecutively recruited from those who presented for immunization in the University of Benin Teaching Hospital, Benin. The bio-data and other relevant information were obtained using a proforma. The anthropometric measurements of the children were obtained and the children were examined for presence of a BCG scar.
Results: Two hundred and six subjects (96.3%) had a postvaccination BCG scar. About 72% of the subjects were vaccinated within the first week of life. The age at vaccination was significantly affected by gestational maturation (P=0.003) and birth weight (P=0.0001). Gestational maturation is a strong predictor of BCG scar formation postvaccination (P = 0.007)
Conclusion: There is high prevalence of BCG scar formation in this study and gestational maturation is a strong predictor of BCG
scar formation.
Downloads
Published
Issue
Section
License
This is an open-access journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 License, which allows others to remix, transform, and build upon the work even, commercially, as long as appropriate credit is given to the author, and the new creations are licensed under identical terms